Search Results 221-230 of 14481 for Histamine
... histamines) and anti-cholinergics. TMS shows sufficient MEP amplitude and/or NCS studies show sufficient CMAP amplitude. ALS Subject Exclusion Criteria ...
Latest stories · Mayo researchers develop AI-enhanced strategy to personalize medication alerts featured image · Innovative blood analysis technique reveals ...
... histamine H2 blocker (e.g., cimetidine, famotidine, nizatidine, ranitidine) within 2 days prior to the start of study therapy. Concurrent participation in ...
Learn about navigating regulatory pathways that advance promising biotherapies to daily patient care at RegenBio Summit: Transforming Next-Gen Biotherapeutics ...
Medical evaluation and management of patients with congenital heart disease; Echocardiography: fetal, pediatric, adult congenital heart disease, ...
Mayo Clinic researchers can more precisely detect and monitor brain cell activity during deep brain stimulation, a treatment for Parkinson's disease and tremor.
Mayo Medical Laboratories, National Decision Support Company team up to develop CareSelect™ Blood, a comprehensive approach to patient blood management.
Latest stories · New genomic test could spare some people with melanoma from lymph node biopsy surgery featured image · Breast cancer survivors find relief for ...
Mayo Clinic and Mercy reach first major milestone in data collaboration. Decades of data can now be used to pinpoint diseases earlier and transform ...
Use of proton pump inhibitors (PPIs) and histamine 2 receptor antagonists (H2RAs) ≤ 2 weeks prior to baseline visit and during study duration. Diagnosis of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.